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Abstract
Recently, there has been an increased interest in imaging different pulmonary 
disorders using PET techniques. Previous work has shown, for static PET/
CT, that air content in the lung influences reconstructed image values and 
that it is vital to correct for this ‘tissue fraction effect’ (TFE). In this paper, 
we extend this work to include the blood component and also investigate 
the TFE in dynamic imaging. CT imaging and PET kinetic modelling are 
used to determine fractional air and blood voxel volumes in six patients with 
idiopathic pulmonary fibrosis. These values are used to illustrate best and 
worst case scenarios when interpreting images without correcting for the TFE. 
In addition, the fractional volumes were used to determine correction factors 
for the SUV and the kinetic parameters. These were then applied to the patient 
images. The kinetic parameters K1 and Ki along with the static parameter SUV 
were all found to be affected by the TFE with both air and blood providing a 
significant contribution to the errors. Without corrections, errors range from 
34–80% in the best case and 29–96% in the worst case. In the patient data, 
without correcting for the TFE, regions of high density (fibrosis) appeared to 
have a higher uptake than lower density (normal appearing tissue), however 
this was reversed after air and blood correction. The proposed correction 
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methods are vital for quantitative and relative accuracy. Without these 
corrections, images may be misinterpreted.
Keywords: lung, PET/CT, tissue fraction correction, 18F-FDG, idiopathic 
pulmonary fibrosis
(Some figures may appear in colour only in the online journal)
1. Introduction
Recently whole lung PET/CT imaging has become a popular methodology for studying a 
variety of inflammatory, infectious, obstructive and fibrotic pulmonary diseases (Groves et al 
2009, Inoue et al 2009, Win et al 2012, Abdulla et al 2014). Imaging the lung is known to be 
difficult due to respiratory motion and this has been extensively explored within the literature 
(Nehmeh and Erdi 2008, Sun and Mok 2012). However little attention has been given to the 
tissue fraction effect (TFE).
The TFE, a component of the partial volume effect, is the result of the finite size of an 
image voxel. In the lung, the average size of an alveolus is approximately 0.008 mm3(Ochs 
et al 2004), 6000 times smaller than the typical PET voxel. Consequently, a single voxel will 
contain air and multiple tissue components including blood and parenchyma. The resulting 
voxel value will then be an average of the tracer concentrations within that voxel and not the 
signal from the parenchyma alone as required.
The importance of correcting for the air component in the lung in PET/CT SUV studies 
has already been presented for patients with idiopathic pulmonary fibrosis (IPF) (Lambrou 
et al 2011, Win et al 2012, 2014). This fatal restrictive fibrotic disease is characterized by an 
increase in lung scar tissue which distorts the normal parenchyma architecture resulting in 
regions of dense tissue with large air pockets (Meltzer and Noble 2008). In this patient group 
an increase in 18F-FDG uptake was seen in regions of fibrosis in comparison to normal appear-
ing lung regions (Groves et al 2009). As there is a greater tissue component in the fibrotic 
regions, consideration was given to the TFE. By taking into account the lung air content, it was 
shown that the uptake distribution actually appeared uniform throughout the lung (Lambrou 
et al 2011, Win et al 2012, 2014). Correcting for the air component therefore alters image 
interpretation.
Another contribution to the TFE, the blood, has not been explored yet in the literature. 
Blood is a large component of the lung voxel (∼20%) (Wollmer et al 1984) and adds to the 
PET signal. It therefore affects voxel concentration and must be accounted for. There are 
many published methods for determining blood volume within the lung including indicator 
dilution (Dock et al 1961), radiocardiographic techniques (Lewis et al 1970), cardiovascular 
magnetic resonance (Ugander et al 2009, Kanski et al 2013) and dual energy CT acquisitions 
(Fuld et al 2013). Unfortunately, these techniques are either invasive, use contrast agents not 
suitable for all patients and/or result in whole lung blood volume estimates and not regional 
or local values. An alternative method, which is utilised in this paper, is to use dynamic PET 
acquisitions to estimate blood volume at a voxel level (Gunn et al 2002).
As PET/CT imaging of whole lung diseases is still poorly understood, dynamic analysis is 
also being used to explore tracer and drug kinetics (Jones et al 1998, Chen and Schuster 2006, 
Schroeder et al 2008, De Prost et al 2010, Schroeder et al 2011, Dittrich et al 2012). However, 
to date the influence of the TFE on the kinetic parameters has not been studied.
In this paper we develop methods for correcting for the TFE in both static SUV studies 
and kinetic analysis. We investigate the possible parameter estimate errors if the air and blood 
B F Holman et alPhys. Med. Biol. 60 (2015) 7387
7389
components of the TFE are not accounted for. Finally, we apply these corrections to patient 
data to determine the significance of correcting for air and blood.
2. Theory
2.1. Air fraction correction in static imaging
Lung voxel air fraction correction (AFC) was first discussed by Lambrou et al (2011). In their 
paper, Lambrou et al assume that a lung voxel contains only two components, air and tissue, 
where tissue is the combination of both parenchyma (the non-blood cellular and extra cellular 
components that make up the lung) and blood. Under this assumption, the Hounsfield Units 
(HU) within a CT voxel can be considered as
= +V VHU HU HUl a a t t (1)
where HUl, HUa and HUt are the HU of the lung voxel (CT voxel value), air and tissue respec-
tively and Va and Vt are the fractional air and tissue volumes in the voxel respectively, where 
+ =V V 1a t . Therefore, once the CT has been filtered to the resolution of the PET image and 
downsampled, the PET voxel fractional air volume can be determined from simple rearrange-
ment of equation (1):
= −
−
V
HU HU
HU HU
.a
l t
a t
 (2)
The PET concentration can then be corrected using equation (3):
=
−
C
C
V1
.t
measured
a
 (3)
Where Cmeasured is the measured (non-corrected) tracer concentration and Ct is the tracer 
concentration in tissue after AFC. Once the AFC has been applied, the corrected voxel values 
are those that would have been present without the air component (i.e. just blood and paren-
chyma). However, to obtain an accurate parenchyma fraction, as is required, a further correc-
tion for blood is needed.
2.2. Blood fraction correction in static imaging
Equation (1) can be expanded to include the blood component as follows:
= + +V V VHU HU HU HUl a a b b pa pa (4)
where HUb and HUpa represent the HU of blood and parenchyma respectively (which are 
approximately equivalent (Hounsfield 1980)) and Vb and Vpa are the fractional blood and 
parenchyma volumes in the voxel respectively.
Image concentration can be corrected for the parenchyma fraction as before with Vpa (where 
= − −V V V1pa a b) replacing − V1 a in equation (3). However, the significant amount of blood 
in the lung voxel also makes it vital to correct for any PET signal that may originate from 
blood. Therefore the complete correction for the concentration becomes:
= − = −
− −
C
C V C
V
C V C
V V1
pa
measured b b
pa
measured b b
a b
 (5)
where Cb is the blood concentration, determined from an aorta or ventricle region of interest 
(ROI). In this paper we demonstrate that equation (5) is far more appropriate than equation (3) 
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for comparing between patients and between patients and controls. The difficulty is that the 
static PET/CT does not provide information on Vb, unlike Va which can easily be calculated 
from the CT image. However, Vb can be estimated directly from kinetic analysis if it is included 
in the model fit (section 3.4).
2.3. Correcting kinetic parameters for the TFE
Standard kinetic modelling methods are formulated assuming that the voxel or ROI contains only 
parenchyma and blood, i.e. + =V V 1b pa . The voxel concentration can then be assumed to be:
= + ( − )C V C V C1v b b b pa (6)
where Cv, Cb and Cpa are the activity concentrations in the voxel (or ROI), blood and paren-
chyma respectively. Equation (6) allows the simultaneous fit of Vb and the kinetic parameters 
of the chosen model for Cpa (Tsoumpas and Thielemans 2009). Now, consider the lung case 
where air is present such that + ≠V V 1b pa  but + + =V V V 1b pa a , then the appropriate air and 
blood corrected (ABC) model would be:
= + ( − − ) +C V C V V C VC1v b b b a pa a a (7)
where Ca is the tracer concentration in air. Ca will be zero unless the tracer has been adminis-
tered using the inhalation method.
To correctly determine the kinetic parameters, one of three methods can be utilised: (1) use 
a model that follows general equation (6) and then correct the estimated parameters affected 
by the TFE by multiplication of ( − ) ( − − )V V V1 / 1b b a , (2) directly fit a kinetic model to the 
measured data using equation (7), (3) precorrect the dynamic images for Va (as in section 2.1) 
and then fit the data as follows:
= + ( − )′ ′ ′C V C V C1v b b b pa (8)
where = ( − )′C C V/ 1v v a  and
=
−
′V V
V1b
b
a
 (9)
which is the blood volume as a fraction of the tissue.
To determine which of the estimated kinetic parameters will change after the corrections 
to equation (6) have been applied, consider the corrected general equation for a compartment 
model (Gunn et al 2002):
∑ ϕ( ) = ( ) + ( − ) ⊗ ( )′ ′ ′ θ
=
−C t V C t V C t1 e
i
n
i
t
v b b b
1
p
i (10)
where, n is the number of compartments in the model, θi is the clearance from compartment i, 
ϕi the applied weighting and Cp the concentration in the plasma. From this equation it can be 
seen that it is the ϕi parameters that will be affected by the TFE. As ϕ=∑ =K i
n
i1 1 , the delivery 
of the tracer to the tissue, it is only K1 and any parameter containing K1 (e.g. the influx rate 
constant (Ki)) that will require corrections.
As Ki is affected by the TFE, all of the above theory is also applicable to Patlak analysis 
(Patlak et al 1983) where the corrected curve equation would be:
∫−
( − )
=
( )
+
′ ′
′
C V C
C V
K
C t t
C
D
1
d
i
t
v b b
p b
0 p
p
 (11)
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where D is the intercept of the tissue fraction corrected Patlak curve. Unfortunately, as is the 
case with static image analysis, equation (11) requires knowledge of ′Vb, a parameter not nor-
mally determined during Patlak analysis. However, ′Vb can be determined from the early part 
of the time activity curve (TAC), see section 3.4.
3. Methods
3.1. Patient data acquisition
Six patients, three males and three females aged ±70 5 yrs all with diagnosed IPF under-
went 18F-FDG dynamic PET/CT using a GE Discovery VCT PET/CT scanner (Teras et al 
2007). All patients were imaged supine immediately post-injection using ±200 26 MBq 
18F-FDG with the protocol outlined in table 1. Cine-CT imaging was acquired with a duration 
equivalent to the patients complete breathing cycle plus one second. Five of the six patient 
scans were obtained from an ongoing study (NCT01725139) designed to explore a number of 
doses of GSK2126458 for engagement of pharmacology in subjects with IPF after short term 
dosing. The remaining patient’s scan was part of an ongoing study (MREC 06/Q0505/22) 
designed to explore the prognostic value of PET/CT in patients with interstitial lung disease. 
Institutional Review Board permission and informed patient consent were obtained for both 
studies and MHRA approval was obtained for study NCT1725139.
3.2. Simulations—kinetic analysis
To investigate the errors associated with not accounting for air and blood within a voxel, four sim-
ulated TACs were created based on real patient parameters. These TACs were constructed to rep-
resent best and worst case scenarios for investigating the difference between normal and fibrotic 
regions. A best case scenario is where the difference in the fraction of parenchyma in the fibrotic 
and normal appearing tissue is as low as possible. This would give rise to similar PET voxel sig-
nals in both cases and would occur when the normal appearing regions have the lowest possible 
blood and air fractions (greatest possible parenchyma fraction) and the fibrotic regions have the 
highest air and blood fractions. Conversely, the worst case scenario is where the difference in the 
fibrotic and normal appearing tissue parenchyma fractions is high. Under these circumstances, the 
average PET voxel values in each region would appear to have the greatest contrast.
To achieve realistic values for the four TAC simulations, we used results obtained from 
patient analysis (section 3.4). Va and Vb were calculated for all six patients to determine the 
highest and lowest air and blood fractions in the fibrotic and normal appearing regions (see 
table 2). An example patient derived input function (IF) was also determined. Additionally a 
set of kinetic parameters (K1, k2 and k3) from a single patient were estimated for the whole 
lung TAC using the recommended FDG kinetic model, the 2 tissue irreversible compartment 
model (2-ICM) (Sokoloff et al 1977).
Table 1. Patient acquisition protocol.
Time post injection Acquisition
Cine CT (1 PET bed) cine duration 4.5–6 s depending on respiratory rate
0 min Patient injection
0 min 20 min dynamic PET (1 bed) ×6 10 s, ×3 20 s, ×3 60 s, ×5 120 s, ×1 300 s
20 min Patient break (free to move)
30 min Cine CT (1 PET bed) cine duration same as in previous acquisition
35 min 20 min dynamic PET (1 bed) ×4 300 s
B F Holman et alPhys. Med. Biol. 60 (2015) 7387
7392
Having estimated a patient’s whole lung kinetic parameters, the four simulated noise free 
TACs were created where only the air and blood fractions were varied using:
( ) = ( ) + ( − − ) ( )t V t V V tTAC IF 1 TrueCurveb a b (12)
where TrueCurve is the simulated parenchyma response using the 2-ICM with the known 
patient derived kinetic parameters.
For each TAC the kinetic parameters were estimated using the 2-ICM and with Patlak 
analysis. The percentage difference between the true and estimated parameters with no cor-
rections (NC), blood fraction correction (BFC) only and AFC only were determined in order 
to calculate the errors caused by not applying the full ABC correction method. The percent-
age difference between parameters determined in the normal and fibrotic regions were also 
calculated in each case as may be considered when only relative and not absolute comparison 
is required.
3.3. Simulations—SUV
The standardised uptake value (SUV) is the most common parameter used in the clinical set-
ting (Thie 2004). It is a measure of concentration normalised to the injected activity (A) and 
the patients weight (W ):
= C
A W
SUV
/
v
 (13)
Errors in SUV associated with not accounting for air and blood within a voxel were inves-
tigated. As in section 3.2, best and worst cases were created. In addition, two patient represen-
tations were determined (based on the data from the six patients), each with different blood 
tracer concentrations. This is because SUV, unlike the kinetic parameters, is affected by the 
concentration in blood as well as the Vb, introducing a further source of error specific to com-
parisons between patients and between patients and controls.
For the simulations, the final time point of the TrueCurve derived in section 3.2 was used to 
represent the true whole lung parenchyma concentration (and hence SUV) in a static image. 
The best and worst case concentrations for the fibrotic and normal appearing regions were 
achieved by applying the simple re-arrangement of equation (5) and using the Va and Vb values 
in table 2. For the concentration in blood, the mean and standard deviation of the aorta con-
centrations at the final time point for all six patients was determined. The two Cb values used 
were the mean ±1 standard deviation.
To determine the maximum and minimum errors that may be expected if the full ABC cor-
rection is not applied, the percentage differences between the NC, BFC and AFC and the true 
parenchyma concentration, between the values determined from the different blood concen-
trations and between fibrotic and normal appearing tissues were calculated.
Table 2. Patient derived air, blood and parenchyma fractions in fibrotic and normal 
appearing regions for the best and worst case scenarios.
Air fraction  
Va
Blood fraction  
Vb
Parenchyma fraction 
Vpa
Best case ‘Fibrotic’ 0.43 0.18 0.39
Best case ‘Normal’ 0.66 0.14 0.20
Worst case ‘Fibrotic’ 0.37 0.15 0.48
Worst case ‘Normal’ 0.75 0.19 0.06
B F Holman et alPhys. Med. Biol. 60 (2015) 7387
7393
3.4. Patient analysis
PET images were reconstructed using FBP with an average of the Cine-CT acquisition for 
attenuation correction. The average Cine-CT was used to minimise any CT-PET mismatch 
due to respiratory motion (Pan et al 2005). As the patients were allowed to move between 
the two study sections, the two average Cine-CT images were registered using a non-rigid 
technique with the NiftyReg software (Ourselin et al 2001, Modat et al 2010) and the trans-
formation fields applied to the appropriate PET images. The PET images then underwent 
AFC with the correction factors derived from the average Cine-CT as described in section 2.1. 
The concentration of activity in blood at each time point was determined using a 3D ROI 
drawn manually on the aorta. The aorta was identified on fused PET and CT (using early PET 
frames). A previously defined model (Sari et al 2014) was then used to fit these data points to 
produce an input function (IF).
Vb was determined on a voxel basis using the first minute of the initial dynamic acquisition. 
High voxel TAC noise rendered full compartment modelling impractical with poor fit stability 
even after image smoothing. Vb was therefore considered as the scaling factor between the TAC 
and the IF allowing a model fitting Vb and time delay (between the TAC and IF) to be used. With 
image smoothing using a Gaussian filter with a 12 mm FWHM, this method resulted in fast 
processing with high stability. To calculate ′Vb, the same method was adopted with AFC applied 
to the images prior to smoothing to ensure correct match between PET and CT.
For each patient, the average cine-CT was used to segment the lungs using a threshold-
ing technique to create a whole lung mask (WLMask). The fractional parenchyma volume 
maps were reviewed and any voxels with a value of  <5% were removed from the WLMask to 
ensure voxels containing mostly air (e.g. bullae) or mostly blood (i.e. blood vessels) were not 
analysed. Regions within this WLMask were then further segmented to separate regions of 
higher density (HDMask) representative of fibrosis and lower density (LDMask) representa-
tive of normal appearing tissue. For each patient, SUV and voxel based Patlak analysis were 
applied to the regions within each of the HD and LD masks. AFC and ABC were applied to 
the patients as described in section 2 and the masks were used to compare average regional 
results before and after corrections. In all cases, kinetic analysis was performed using in-house 
validated software.
4. Results
4.1. Simulations—kinetic analysis
Table 3 displays the results of ignoring the TFE for the worst and best case scenarios. The 
‘True’ values represent the correct parameters after ABC (i.e. with no air or blood present). 
The results confirm that the only parameters affected by the TFE are K1 and Ki both in the case 
of 2-ICM and Patlak analysis. The TFE causes the affected kinetic parameters to be underesti-
mated and this error reduces with BFC and AFC. It can also be seen that the determined Vb is 
not affected by the presence of air (table 2).
Table 4 lists the percentage differences between the true and calculated Ki after each cor-
rection. The TFE causes the affected kinetic parameters to be underestimated by 96–52% 
without any corrections and this error reduces with both BFC and AFC.
Table 5 is a comparison between the normal and fibrotic regions in each case. As the TACs 
were all determined from the same parameters, then the true Ki should be identical in all cases. 
As can be seen, not correcting for the presence of air and blood results in a significant error 
with Ki appearing between 49% and 92% different.
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4.2. Simulations—SUV
The average whole lung parenchyma concentration in a static image, as determined from the 
simulated ABC TAC, was found to be 3.4 kBq ml−1. The mean blood concentration for the 
six patients was found to be ±3.9 1.2 kBq ml−1 therefore the blood concentrations used to 
represent two patients were Cb1 = 5.1 kBq ml−1 and =C 2.8b2  kBq ml−1.
Table 6 lists the concentrations and their percentage differences (in brackets) from the true 
result in each case, with and without corrections. As can be seen, if the correction for blood 
fraction is applied without correcting for air, then the parameter estimate accuracy is decreased 
in comparison to no correction at all. As with the kinetic parameters, all concentrations are 
Table 3. Determined kinetic parameters with no corrections applied.
K1 K2 K3 Ki2 KiP Vb
True 0.17 0.51 0.0203 0.0065 0.0065 *
Best case
Fibrosis 0.07 0.51 0.0203 0.0025 0.0025 0.18
Normal 0.03 0.51 0.0203 0.0013 0.0013 0.14
Worst case
Fibrosis 0.08 0.51 0.0203 0.0031 0.0031 0.15
Normal 0.01 0.51 0.0203 0.0003 0.0003 0.19
* See table 2 for the true Vb for each case.
Ki2 = influx rate determined from the 2-ICM.
KiP = influx rate determined from Patlak analysis.
Note these two methods should (and do) produce the same result.
Table 4. Percentage difference between the true and measured Ki before and after 
blood or air corrections.
NC BFC AFC
Best case
Fibrosis −61% −52% −32%
Normal −80% −77% −41%
Worst case
Fibrosis −52% −44% −24%
Normal −96% −95% −83%
NC = No Correction,
BC = ( − )K V/ 1i b ,
AFC = ( − )K V/ 1i a .
Table 5. Percentage difference between Ki in the two regions (normal/fibrotic) in each 
case before and after blood or air corrections.
NC BFC AFC
Best case −49% −51% −14%
Worst case −92% −91% −77%
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underestimated with an error range of 81% to 29% when no corrections have been applied. 
After AFC this error still ranges from  −4% to 41%. AFC without BFC can also be seen to 
overestimate the concentration when Cb is greater than the concentration in the parenchyma. 
Complete correction is only obtained after ABC.
The percentage difference between the two patient simulations was found to range between 
17% and 67% without any corrections. As the only variation is the blood concentration, BFC 
alone causes the concentrations in both patients to be equal in each case (although underesti-
mated by up to 96% due to the presence of air).
Table 7 is the percentage difference between the normal and fibrotic regions for a relative 
comparison. In the best case situation, after AFC, the concentrations are within 5% and there-
fore could be considered as approximately equivalent, however, this is not true for the worst 
case scenario where the difference is still as high as 26%.
4.3. Patient analysis
Figure 1 displays the fibrotic (HD) and normal appearing (LD) Patlak derived influx rate 
constant (KiP) for the NC, AFC and ABC cases for all six patients. It can be seen that in 
all patients the HD regions have a higher KiP than that of the LD region in the NC case 
( p   =   0.01). After AFC, the regions become comparable with a p value of 0.35 and after 
ABC, the LD regions are significantly increased with respect to the HD regions ( p   =   0.01). 
Table 6. Determined average parenchyma static concentrations before and after 
corrections for each region and case and their percentage difference to the true 
concentration, 3.4 kBq ml−1.
NC BFC AFC
Cb1 Cb2 Cb1 Cb2 Cb1 Cb2
Best Case
Fibrosis 2248 1827 1328 1328 3944 3206
(−34%) (−46%) (−61%) (−61%) (−16%) (−6%)
Normal 1397 1070 681 681 4108 3146
(−59%) (−69%) (−80%) (−80%) (−21%) (−8%)
Worst Case
Fibrosis 2401 2050 1634 1634 3811 3255
(−29%) (−40%) (−52%) (−52%) (12%) (−4%)
Normal 1108 664 136 136 4816 2886
(−67%) (−81%) (−96%) (−96%) (41%) (−15%)
Note: Cb1 and Cb2 are the blood concentrations and are equal to 5.1 kBq ml−1 and 2.8 kBq ml−1 
respectively.
Table 7. Percentage difference between measured concentrations in the two regions 
(normal/fibrotic) in each case before and after corrections.
NC BFC AFC
Cb1 Cb2 Cb1 Cb2 Cb1 Cb2
Best Case −38% −41% −49% −49% 4% −2%
Worst Case −54% −68% −92% −92% 26% −11%
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Figure 2 is the SUV equivalent to figure 1 where it can be seen that the trend is similar to the 
KiP case with the HD regions appearing significantly higher than the LD regions in the NC 
case ( p   =   0.0001), approximately equivalent after AFC ( p   =   0.092) and significantly lower 
in the ABC case ( p   =   0.0001).
Figure 3 displays an example parametric KiP image for each correction method. In the top 
left (a) the CT image can be seen displaying obvious regions of fibrosis (white arrows) and a 
region of normal appearing tissue (black arrow). In the top right (b) is the parametric image 
with no corrections displaying an apparent high influx rate in regions of fibrosis in comparison 
to those of normal appearance. In the bottom left (c) is the AFC image where the influx rate 
appears more uniform throughout the lung and after ABC (d) the regions of fibrosis appear to 
have a lower influx rate than those of normal appearance. Figure 4 displays the SUV results 
in the same layout as figure 3.
Figure 1. Bar graphs displaying the difference in Ki in fibrotic (light grey bars) and 
normal (dark grey bars) appearing regions determined from the mean of the HDMask 
and LDMask (with  >5% fractional parenchyma volume threshold) over the Ki Patlak 
parametric images for all analysed patients. In the top chart, no corrections have been 
applied, the middle chart displays the values following AFC and the bottom chart is 
after ABC. Note that the influx rate appears higher in fibrotic regions when compared to 
the normal appearing regions without corrections but lower after correction.
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5. Discussion
Air and blood are significant components of the lung and have a considerable effect on the 
measured PET voxel tracer concentration. The result of not accounting for these components 
is a significant underestimation of the parenchyma signal. Moreover, the extent of this error is 
dependent on the highly variable voxel blood and air fractions throughout the lung.
Fractional air volume in static imaging has been previously discussed (Lambrou et al 2011) 
where it was shown, in agreement with the results found here, that SUV within the IPF lung 
appears more uniform after AFC. Lambrou et al were the first to note that the air component 
can lead to inaccurate parameter estimates and misinterpretation of results in SUV imaging 
and this is especially true when comparing between different lung density regions in a single 
Figure 2. Bar graphs displaying the difference in SUV in fibrotic (light grey bars) and 
normal appearing regions (dark grey bars) determined from the mean of the HDMask 
and LDMask (with  >5% fractional parenchyma volume threshold) over the final 
dynamic PET frame for all analysed patients. In the top chart, no corrections have been 
applied, the middle chart displays the values following AFC and the bottom chart is 
after ABC. Note that the SUV appears higher in fibrotic regions when compared to the 
normal appearing regions without corrections but lower after correction.
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patient, between patients and/or between patients and controls. Here this methodology has 
been expanded to include blood correction in both static and dynamic analysis.
Table 6 highlights the need for correcting for air fraction in static imaging where the error 
after AFC can be seen to reduce from 81% to 41% in the worst case and 29% to 4% in the best 
case. However, AFC may over or under correct the concentration depending on whether the 
Cb is greater or lower than Cpa respectively. This indicates that for static imaging, using AFC 
alone is not sufficient for comparison between patients.
Kinahan and Fletcher (2010) found SUV test-retest variability to be as high as ±20%, 
therefore here we consider this as the upper limit of acceptable error. When comparing differ-
ent regions in a single patient with high Cb (table 6), it can be seen that after AFC, only in the 
fibrotic regions are the results below this limit. When considering relative change between the 
different density regions (table 7), only in the best case scenario can the HD and LD regions be 
considered comparable. AFC alone is therefore not enough for accurate image interpretation 
within a single patient and ABC is vital.
ABC is important as the blood volume as a fraction of tissue can be as high as 75% in nor-
mal appearing regions and 32% in the presence of fibrosis. This high blood volume is also the 
cause of the change in SUV error when two different blood concentrations are applied with no 
Figure 3. Patlak Ki parametric images from an example patient. Image (a) is the CT 
displaying regions of obvious fibrosis (white arrows) and a region of normal appearing 
tissue (black arrow). Image (b) is the uncorrected parametric image, image (c) is the 
same image after AFC and image (d) after ABC. All images have been normalised such 
that they can be shown on the same arbitrary grey scale. All images are shown after 
whole lung masking with  >5% fractional parenchyma volume thresholding.
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other alterations to the two static simulations (tables 6 and 7). As blood concentration would 
not be the only difference between patients, these results are best case limits.
Vb cannot be ascertained for static imaging using current clinical protocols and therefore 
ABC cannot be applied. However Vb can be determined from a one minute dynamic acquisi-
tion immediately after injection. The addition of this short dynamic to the imaging protocol 
could reduce the error in the calculated concentration by 81%, significantly improving image 
interpretation (table 6).
The characterisation of systematic errors associated with not performing ABC was achieved 
with use of noise free TACs. In this work we have not compared this bias with the random 
errors due to noise in the data. An investigation into error propagation due to noise in the cor-
rection factors is left for future work.
Although AFC is only required for the lung, BFC can be applied throughout the body. BFC 
is not commonly utilised in areas such as the brain or oncology ether due to the necessity of 
dynamic imaging to obtain Vb or because Vb is regularly considered negligible. However, BFC 
is vital in regions in which the blood volume is high, variable across the ROI, or where uptake 
within the blood is high with respect to that of the tissue of interest, all of which are true in 
the lung case.
In this paper we have used a voxel-wise method for correcting for the TFE. This method 
is limited by the accuracy of the PET/CT registration and resolution matching, a difficult 
Figure 4. Example SUV images from a single patient. Image (a) is the CT as in 
figure 3(a). Image (b) is the uncorrected SUV image (grey scale 0–1.5 SUV), image 
(c) is the same image after AFC (grey scale 0–3.5 SUV) and image (d) after ABC (grey 
scale 0–12 SUV). All images are shown after whole lung masking with  >5% fractional 
parenchyma volume thresholding.
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problem in the lung. In addition, in voxels that contain low parenchyma fractions, such as in 
airways, bullae and blood vessels, the corrected values will be sensitive to noise and errors in 
the estimated Va and Vb. We have addressed these problems by using averaged Cine-CT data to 
match the PET as closely as possible, and by excluding voxels with <V 5pa % from the analy-
sis. Alternatively, a method using average correction factors for a ROI could be used. This is 
advantageous for regions with uniform PET tracer delivery and uptake kinetics. However, the 
time for the PET tracer to reach different parts of the lung is known to be variable. Moreover, 
it is possible that in the IPF lung, kinetic parameters may vary between different voxels. 
Therefore, a voxel-wise analysis was judged more appropriate. For the patient data, we have 
presented results using Patlak analysis as compartmental modelling was unstable at the voxel 
level due to noise.
Patient data were reconstructed using FBP techniques. This analytical method was used to 
avoid issues with quantification when using iterative reconstruction methods, e.g. due to vari-
able convergence rates and bias in regions of low radiotracer concentration such as the lung.
The tissue fraction correction methodology described in this work was applied to patients 
with IPF. However, it is applicable to imaging of all pulmonary diseases and any organ in 
which air or large fractional blood volumes are present. ABC removes bias due to variations 
in the quantity and uptake of the air and blood components, ensuring that the measured PET 
signal originates from the parenchyma only. However, it is noted that parenchyma may be 
heterogeneous, especially when comparing between the normal appearing and fibrotic regions 
of the lung. Therefore, the use of further corrections may need to be investigated.
Application of the tissue fraction correction to the IPF patients displays an inversion of 
initial results. Without correction, it appears that the fibrotic regions have a higher uptake 
(SUV) and influx rate (KiP) than that of the normal appearing regions in the IPF lung. After 
AFC, both regions appear equivalent in SUV and KiP, but after ABC, it is the normal appearing 
regions that have increased parameter estimates and this is consistent between all patients. The 
interpretation of these results would therefore differ depending on which (if any) correction 
method was used.
The observation of increased tracer uptake in the normal appearing regions with respect to 
that of the fibrotic regions is a relative result. Further work is therefore required to determine 
how the different regions may compare to those of a control lung. Win et al (2014) com-
pared normal regions in IPF patients to controls and found, after AFC only, that the normal 
IPF regions have an increased uptake with respect to the controls. However, here it has been 
shown that a 67% difference can be found in two patient groups with the same parenchyma 
concentration but with different blood concentrations. Therefore, the results of Win et al need 
confirmation by taking the blood component of the TFE into account.
6. Conclusion
Methods for correcting for the air and blood components in a lung voxel have been described 
for SUV and dynamic analysis. These methods are an extension of previously published work 
which used CT to account for differences in air fraction in static imaging. We have used a short 
dynamic scan to determine blood fraction and demonstrated that in the lung, the combination 
of air and blood fraction correction is essential for obtaining accurate parameter estimates in 
both dynamic and static imaging. Application of these corrections in patients with IPF has 
been shown to change the interpretation of results and to be vital for comparisons between 
different density regions in a single patient, between patients and/or between patients and 
controls.
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